Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
Active, not recruiting · NCT04420754 · Registry updated 2025-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer | Disease Attributes, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, carcinoma, epithelial neoplasm, neoplasm, thyroid gland undifferentiated (anaplastic) carcinoma | Active, not recruiting | Phase 1 | 2025-03-30 | NCT04420754 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AffyImmune Therapeutics, Inc. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope National Medical Center, City of Hope Medical Center | Duarte | United States | 1 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Northwestern Memorial Hospital | Chicago | United States | 129 |
| Weill Cornell Medical College | New York | United States | 58 |